EUVIMEDEUVIMED entdecken
Crossref

Detection and evaluation of the presence of the BRAF V600E mutation in ameloblastomas in an Indian population

Cassandra F Goes, Anita Spadigam, Anita Dhupar, Karla M Carvalho, Jochima Cota, Shaheen Syed

Indian Journal of Pathology and Microbiology · 2023

DOI: 10.4103/ijpm.ijpm_398_21 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, 2023. Verfasst von Cassandra F Goes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Pathology, Goa Dental College and Hospital, Bambolim, Goa, India. Hauptthemen laut MEDLINE: Ameloblastoma, Odontogenic Tumors, Mouth Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Ameloblastoma is a benign epithelial odontogenic neoplasm that constitutes approximately 1% of all oral tumors and about 9 to 11% of all odontogenic tumors. They are slow-growing, locally invasive, and demonstrate a potential for metastasis and malignant transformation. The molecular pathogenesis of ameloblastoma is attributed to aberrant activity of the signal transduction pathways relating to developmental stages of odontogenesis including the mitogen-activated protein kinase (MAPK) pathway. The BRAF V600E mutation was identified as the most frequently mutated gene in this neoplasm. Studies have shown that use of BRAF inhibitors in patients diagnosed with ameloblastomas led to a significant reduction in tumor volume.

Aims

To detect the expression of BRAF V600E mutation in ameloblastomas in an Indian population using immunohistochemistry. To compare the difference in the occurrence of the BRAF V600E mutation between mandibular and maxillary cases. Materials and Methods: Thirty-three formalin-fixed paraffin-embedded tissues of histopathologically proven cases of ameloblastoma were assessed for the BRAF V600E mutation by immunohistochemistry using the BRAF V600E monoclonal antibody. Patient data such as age, sex, anatomical site, recurrence were documented. Statistical Analysis: The statistical analysis was performed using the Pearson Chi-square test and Student's t-test.

Results

The present study revealed a high expression of the BRAFV600E mutation in mandibular cases of ameloblastoma among Indians irrespective of the age, sex, site, recurrence or histological pattern.

Conclusions

The identification of this driver mutation opens the possibility of an adjuvant therapeutic modality to reduce the significant facial disfigurement and morbidity following surgical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmeloblastomaOdontogenic TumorsMouth NeoplasmsHumansProto-Oncogene Proteins B-rafMutation

Stichwörter der Autor:innen

AmeloblastomaBRAF V600E mutationimmunohistochemistry

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Pathology, Goa Dental College and Hospital, Bambolim, Goa, India.

Zitieren

APA

Goes, C. F., Spadigam, A., Dhupar, A., Carvalho, K. M., Cota, J., & Syed, S. (2023). Detection and evaluation of the presence of the BRAF V600E mutation in ameloblastomas in an Indian population. Indian Journal of Pathology and Microbiology. https://doi.org/10.4103/ijpm.ijpm_398_21

Vancouver

Goes CF, Spadigam A, Dhupar A, Carvalho KM, Cota J, Syed S. Detection and evaluation of the presence of the BRAF V600E mutation in ameloblastomas in an Indian population. Indian Journal of Pathology and Microbiology. 2023. doi:10.4103/ijpm.ijpm_398_21

BibTeX
@article{Goes2023,
  author = {Goes, Cassandra F and Spadigam, Anita and Dhupar, Anita and Carvalho, Karla M and Cota, Jochima and Syed, Shaheen},
  title = {Detection and evaluation of the presence of the BRAF V600E mutation in ameloblastomas in an Indian population},
  journal = {Indian Journal of Pathology and Microbiology},
  year = {2023},
  doi = {10.4103/ijpm.ijpm_398_21}
}
Kostenlos starten →